Evaluation of vinblastine (VBL), bleomycin (BLEO), and cis-platin (CPDD) as second trial therapy in patients with recurrent ovarian carcinoma

C. E. Ehrlich, Frederick Stehman, S. D. Williams

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations
Original languageEnglish
Title of host publicationProceedings of the American Society of Clinical Oncology
VolumeVol. 1
StatePublished - 1982

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ehrlich, C. E., Stehman, F., & Williams, S. D. (1982). Evaluation of vinblastine (VBL), bleomycin (BLEO), and cis-platin (CPDD) as second trial therapy in patients with recurrent ovarian carcinoma. In Proceedings of the American Society of Clinical Oncology (Vol. Vol. 1)